Proscia and Ibex Medical Analytics are collaborating on software that powers artificial intelligence-enabled workflows for prostate cancer diagnosis.
The partnership is focused on integrating Ibex’s Galen Prostate solution and Proscia’s Concentriq image- and data-management platform to bring AI-powered triaging, cancer detection, and grading of prostate core needle biopsies into routine workflows.
Galen Prostate provides real-time quality control by alerting pathologists to misdiagnosed and misgraded cancers. Concentriq is used for routine image viewing, management, and analysis and serves as a launch pad for computational applications.
The integrated solution will make Galen Prostate available to Concentriq users, beginning with select customers in the United States and Europe.
New to digital pathology? Learn how whole slide imaging is changing the industry here.